Location: Worcester, MA United States
Company: 3W consulting company
Inspired by: Atherosclerotic cardiovascular disease (CVD) such as heart attack and stroke causes over 17 million deaths worldwide annually. Here, we present a new multibioparameter method for quantitatively evaluating individual’s global CVD risk (GR), disease cause, therapeutic target and efficacy, called GRMed. The latest clinic results predict that GRMed could help to save lives, free to CVD and reduce healthcare costs.
|06/23||GRMed: A Multibioparameter Method for Quantitatively Evaluating Individual’s Global Cardiovascular Disease Risk||Medical||3314||0|